HIM
CLB icon

Hermes Investment Management’s Core Laboratories CLB Stock Holding History

Hermes Investment Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-25,430
Closed -$4.25M – 238
2014
Q2 		$4.25M Sell
25,430
-143,479
-85% -$25.5M 0.12% 132
2014
Q1 		$33.5M Buy
168,909
+35,166
+26% +$6.64M 1.06% 43
2013
Q4 		$25.5M Buy
133,743
+77,223
+137% +$14.4M 0.78% 67
2013
Q3 		$9.56M Buy
56,520
+51,820
+1,103% +$8.04M 0.32% 84
2013
Q2 		$713K Buy
+4,700
New +$666K 0.03% 173

Other funds holding CLB

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

Hermes Investment Management's CLB Position: Q3 2014 in Review

Hermes Investment Management sold out of Core Laboratories (CLB) in Q3 2014, closing a stake of 25,430 shares — an estimated $4.25M sold.

Hermes Investment Management first reported a position in CLB in Q2 2013 and held it in 5 quarters. The position peaked at $33.5M in Q1 2014. 344 funds tracked by Wall St. Rank hold CLB as of Q3 2014.

  • Hermes Investment Management reported no remaining Core Laboratories position as of Q3 2014 after selling out during the quarter.
  • Hermes Investment Management sold 25,430 Core Laboratories shares in Q3 2014, an estimated $4.25M.
  • Hermes Investment Management first reported a position in Core Laboratories in Q2 2013 and held it in 5 quarters.
  • Hermes Investment Management's Core Laboratories position peaked at $33.5M in Q1 2014.
  • 344 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2014.

Based on Hermes Investment Management's 13F filing for Q3 2014, filed 12 Nov 2014.